- Latest available (Revised)
- Original (As made)
There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Cosmetic Products (Safety) Regulations 2004. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):
Regulations 5(2) and 7(2)
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in column 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used or contained other than in the types of product specified in column 3. The concentration of the substance, when it is used as a preservative, in a product may not exceed the limit set out in column 4. Where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall not calculated by reference to the mixture. Other requirements are specified in column 5.
In column 4 of this Schedule, “A” indicates that the concentration of the substance in a product may exceed the limit set out in that column provided that —
(b)the presence of any excess of the substance in a product over the concentration so set out is not for the primary purpose of inhibiting the development of micro-organisms; and
(c)the purpose for which any such excess is present in the product is apparent from the labelling of the product.
In this Schedule—
“salt” means salts of the cations sodium, potassium, calcium, magnesium, ammonium and ethanolamines and of the anions chloride, bromide, sulphate and acetate;
“ester” means esters of methyl, ethyl, propyl, isopropyl, butyl, isobutyl and phenyl.
In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
All preservative substances containing formaldehyde or any substances named in this Schedule which release formaldehyde must be labelled with the warning “contains formaldehyde” when the concentration of formaldehyde in the final product exceeds 0.05 per cent.
Names which appear in square brackets in column 2 of this Schedule are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC (1).
Regulation 1(3) provides that until 24th March 2005 entry 36 in Part 1 of this Schedule shall be inserted into Part 1 of this Schedule as it appears in the Cosmetic Products (Safety) Regulations 2003(2). From 24th March 2004 entry 36 shall have effect as it appears in Part 1 of this schedule.
Commencement Information
I1Sch. 6 Pt. I in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I2Sch. 6 Pt. I in force at 11.3.2005 in so far as commenced by inducing reg. 7(2), see reg. 1(2)
(1) | (2) | (3) | (4) | (5) | (6) |
---|---|---|---|---|---|
Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information |
1 | Benzoic acid, its salts and esters | All products | 0.5 per cent (expressed as acid) | A — | — |
2 | Propionic acid and its salts | All products | 2 per cent (expressed as acid) | A — | — |
3 | Salicylic acid and its salts | All products | 0.5 per cent (expressed as acid) | A Not to be used in preparations for children under three years of age except for shampoos | Not to be used for children under three years of age (solely for products which might be used for children under three years of age and which remain in prolonged contact with the skin) |
4 | Sorbic acid (hexa-2,4-dienoic acid) and its salts | All products | 0.6 per cent (expressed as acid) | A — | — |
5 | Formaldehyde and para-formaldehyde | For oral hygiene | 0.1 per cent (expressed as free formaldehyde) | Not to be used in aerosol dispensers (sprays) | — |
6 | ENTRY DELETED | ||||
7 | Biphenyl-2-ol [o-phenylphenol] and its salts | All products | 0.2 per cent (expressed as the phenol) | A — | — |
8 | Pyrithione zinc (INN) [Zinc pyrithione] | Products rinsed off after use | 0.5 per cent | A Not to be used in oral hygiene products | — |
9 | Inorganic sulphites and hydrogen sulphites | All products | 0.2 per cent (expressed as free SO2) | A — | — |
10 | Sodium iodate | Products rinsed off after use | 0.1 per cent | — | — |
11 | Chlorobutanol (INN) | All products | 0.5 per cent | Not to be used in aerosol dispensers (sprays) | Contains chlorobutanol |
12 | 4-Hydroxybenzoic acid and its salts and esters [the Parabens] | All products | 0.4 per cent (expressed as acid) for 1 ester, 0.8 per cent (expressed as acid) for mixtures of esters | A — | — |
13 | 3-Acetyl-6-methylpyran-2,4(3H)-dione [Dehydroacetic acid] and its salts | All products | 0.6 per cent(expressed as acid) | Not to be used in aerosol dispensers (sprays) | — |
14 | Formic acid and its sodium salt | All products | 0.5 per cent (expressed as acid) | A — | — |
15 | 3,3’-Dibromo-4,4’-hexa-methylenedioxydibenzamidine [Dibromohexamidine] and its salts (including isethionate) | All products | 0.1 per cent | — | — |
16 | Thiomersal (INN) [Thimerosal] | Eye make-up and eye make-up remover | 0.007 per cent calculated as mercury. When mixed with other authorised mercury compounds total mercury concentration must not exceed 0.007 per cent | — | Contains thiomersal |
17 | Phenylmercuric salts (including borate) | Eye make-up and eye make-up remover | 0.007 per cent calculated as mercury. When mixed with other authorised mercury compounds total mercury concentration must not exceed 0.007 per cent | — | Contains phenylmercuric compounds |
18 | Undec-10-enoic acid [Undecylenic acid] and its salts | All products | 0.2 per cent (expressed as acid) | A — | — |
19 | Hexetidine (INN) | Products rinsed off after use | 0.1 per cent | A — | — |
20 | 5-Bromo-5-nitro-1,3-dioxane | Products rinsed off after use | 0.1 per cent | Avoid formatation of nitrosamines | — |
21 | Bronopol (INN) [2-Bromo-2-nitropropane-1,3-diol] | All products | 0.1 per cent | A Avoid formatation of nitrosamines | — |
22 | 2,4-Dichlorobenzyl alcohol [Dichlorobenzyl alcohol] | All products | 0.15 per cent | A — | — |
23 | Triclocarban (INN) | All products | 0.2 per cent | A Purity criteria: 3,3’,4,4’-tetra-chloroazobenzene < 1 mg/kg | — |
24 | 4-Chloro-m-cresol [p-Chloro-m-cresol] | Not to be used in products intended to come into contact with mucous membranes | 0.2 per cent | A — | — |
25 | Triclosan (INN) | All products | 0.3 per cent | A — | — |
26 | 4-Chloro-3,5-xylenol [Chloroxylenol] | All products | 0.5 per cent | A — | — |
27 | 3,3’-Bis(l-hydroxymethyl-2,5-dioxoimidazolidin-4-yl)-1,1’-methylenediurea [Imidazolidinyl urea] | All products | 0.6 per cent | A — | — |
28 | Poly(l-hexamethylenebiguanide hydrochloride) [Polyaminopropyl biguanide] | All products | 0.3 per cent | A — | — |
29 | 2-Phenoxyethanol [Phenoxyethanol] | All products | 1.0 per cent | A — | — |
30 | Hexamethylenetetramine (Methenamine (INN)) [Methenamine] | All products | 0.15 per cent | A — | — |
31 | Methenamine 3-chloroallylo-chloride (INNM) [Quaternium-15] | All products | 0.2 per cent | — | — |
32 | 1-(4-Chlorophenoxy)-1-(imidazol-l-yl)-3,3-dimethylbutan-2-one (Climbazole (INN)) [Climbazole] | All products | 0.5 per cent | A — | — |
33 | 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione [DMDM Hydantoin] | All products | 0.6 per cent | A — | — |
34 | Benzyl alcohol (see also Part I of Schedule 4) | All products | 1.0 per cent | A — | — |
35 | 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone and its monoethanolamine salt [Piroctone olamine] | Products rinsed off after use | 1.0 per cent | A — | — |
Other products | 0.5 per cent | A — | |||
36 | 2-Bromo-2-(bromomethyl) glutaronitrile (1,2-dibromo-2,4-dicyanobutane)[Methyldibromo glutaronitrile] | Rinse-off products only | 0.1 per cent | — | — |
37 | 6,6-Dibromo-4,4-dichloro-2,2’-methylenediphenol [Bromochlorophen] | All products | 0.1 per cent | A — | — |
38 | 4-Isopropyl-m-cresol [o-Cymen-5-ol] | All products | 0.1 per cent | — | — |
39 | Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one with magnesium chloride and magnesium nitrate [Methylchloroisothiazolinone and Methylisothiazolinone] | All products | 0.0015 per cent of a mixture in the ratio 3:1 of 5-chloro-2-methylisothiazol-3(2H)-one to 2-methylisothiazol-3(2H)-one | — | — |
40 | 2-Benzyl-4-chlorophenol [Chlorophene] | All products | 0.2 per cent | — | — |
41 | 2-Chloroacetamide [Chloroacetamide] | All products | 0.3 per cent | — | Contains chloroacetamide |
42 | Chlorhexidine (INN) and its digluconate, diacetate and dihydrochloride | All products | 0.3 per cent | A — | — |
43 | 1-Phenoxypropan-2-ol [Phenoxyisopropanol] (see also Part 1 of Schedule 4) | Products rinsed off after use | 1.0 per cent | — | — |
44 | Alkyl (C12-C22)-trimethyl-ammonium bromide and chloride (Cetrimonium bromide (INN) and Cetrimonium chloride (INNM)) | All products | 0.1 per cent | A — | — |
45 | 4,4-Dimethyl-1,3-oxazolidine [Dimethyloxazolidine] | All products | 0.1 per cent | The pH of the finished product must not be lower than 6 | — |
46 | 1-[1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea [Diazolidinyl urea] | All products | 0.5 per cent | — | — |
47 | Hexamidine (INN) (4,4’-(Hexamethylenedioxy)-dibenzamidine) and its salts, including isethionate and p-hydroxybenzoate | All products | 0.1 per cent | A — | — |
48 | Glutaraldehyde (pentane-1,5-dial) [Glutaral] | All products | 0.1 per cent | Prohibited in aerosols (sprays) | Contains glutaraldehyde (where glutaraldehyde concentration in the finished product exceeds 0.05 per cent) |
49 | 5-Ethyl-3,7-dioxa-1-azabicyclo[3.3.0]octane [7-Ethylbicyclo-oxazolidine] | All products | 0.3 per cent | Prohibited in oral hygiene products and in products intended to come into contact with mucous membranes | — |
50 | Chlorphenesin (INN) [Chlorphensin] | All products | 0.3 per cent | — | — |
51 | Sodium N-hydroxymethyl-glycinate [Sodium hydroxymethylglycinate] | All products | 0.5 per cent | — | — |
52 | Silver chloride deposited on titanium dioxide | Not to be used in products for children under three years of age, in oral hygiene products and in products intended for application around the eyes and on the lips | 0.004 per cent, calculated as silver chloride | The ratio of titanium dioxide to silver chloride shall be 4:1 by mass | — |
53 | Benzethonium chloride (INN) [Benzethonium chloride] | Products rinsed off after use | 0.1 per cent | — | — |
54 | Benzalkonium chloride, bromide and saccharinate | All products | 0.1 per cent calculated as benzalkonoium chloride | A — | Avoid contact with eyes |
55 | Benzylhemiformal | Products rinsed off after use | 0.15 per cent | — | — |
56 | 3-lodoprop-2-ynyl butylcarbamate [Iodopropynyl butylcarbamate] | Not to be used in oral hygiene and lip products | 0.05 per cent | — | Contains iodine (Only required where the 3-iodoprop-2-ynyl butylcarbamate concentration in products intended to remain on the skin exceeds 0.02 per cent) |
Commencement Information
I3Sch. 6 Pt. 2 in force at 11.9.2004 in so far as commenced by inducing reg. 5(2), see reg. 1(1)
I4Sch. 6 Pt. 2 in force at 11.3.2005 in so far as commenced by indcuing reg. 7(2), see reg. 1(2)
(1) | (2) | (3) | (4) | (5) | (6) | (7) |
---|---|---|---|---|---|---|
Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information | Permitted for supply until |
Note: There are no entries in this Part at the date that these Regulations are made. |
O. J. No. L132, 1.6..96, p.1.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: